CXCR4 and breast cancer: Similar to CXCR4, ACKR3 is also over expressed in a variety of solid malignancies including prostate and breast cancers and in each of these malignancies it has been shown to drive betta-arrestin-dependent tumor cell adhesion, invasion, survival and growth [34,35].